The Sickle Cell Disease Course is an online educational course for healthcare professionals around the world. This course covers all aspects of SCD clinical management, with content developed by eminent international medical experts, with extensive experience in treating patients with SCD.
The development of this course falls within TIF’s mission to ensure equal access to quality treatment for all SCD patients around the globe. Through this course, TIF hopes to contribute to the lifelong learning of healthcare professionals caring for people with SCD, which ultimately will contribute in enhancing patients’ quality of life.
The course has been reviewed and endorsed by the European Hematology Association (EHA).
Sickle Cell Disease has become a major challenge for all European physicians, and especially hematologists. There are, however, still today, variable levels of knowledge and expertise in European countries, along with insufficient training of general physicians and first line centers. The TIF has created an innovative and excellent tool to increase learning about sickle cell disease, thanks to the participation of the greatest specialists in the field. The European Hematology Association is happy to endorse this very complete e-course. European Hematology Association (EHA)
Aims and objectives
This course aims to offer wide-ranging information and management guidance on every aspect of sickle cell disease. Working with children and adults with this challenging life-long condition, and ensuring their management is optimised, is extremely rewarding. It can greatly improve both their quality of life and life expectancy.
Requirements for participation
Any healthcare professional treating people with the disorder world-wide, who has not necessarily had specialist training about the condition and who wants to learn more about it and the treatment they can offer their patients may enrol in the course.
The course is divided into four sections:
- The first provides background learning about genetics, epidemiology and pathophysiology, screening programmes and an outline of laboratory tests necessary to diagnose and monitor the condition
- The second, and longest section, studies the acute and chronic complications which can affect people with the condition, starting with the commonest – pain and infection, and going on to describe other complications and their management, by organ system.
- The third covers the currently available disease-modifying treatment options of blood transfusion, hydroxycarbamide and haematopoietic stem cell transplantation, finally summarising exciting new treatment options which are becoming available.
- The fourth and final section, outlines some practical aspects of providing services for people with sickle cell disease, including how they may be organised across a range of healthcare settings, and including details of outpatient management for children and adults.
The course is offered free of charge to interested medical specialists worldwide.
You may access the course material by easily creating an account on TIF e-Academy.